Catalyst Wire Dossier Catalyst Wire Dossier

3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution

· Prove pharm
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution, covering 2022-11-30 to 2022-11-30. Get the full timeline:

Most recent: Clinical Trial Update: 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency [Phase 3]

See pricing